Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bupivacaine Injection of Eye Muscles to Treat Strabismus

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Smith-Kettlewell Eye Research Institute
Sponsor:
Collaborators:
Eidactics
Sutter Health
Strabismus Research Foundation
Information provided by (Responsible Party):
Alan B. Scott, Smith-Kettlewell Eye Research Institute
ClinicalTrials.gov Identifier:
NCT01616108
First received: June 7, 2012
Last updated: October 13, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2020
  Estimated Primary Completion Date: September 2019 (Final data collection date for primary outcome measure)
Publications: